Correlation between clinical features and degree of immunosuppression in HIV infected children

D Agarwal1, J Chakravarty, S Sundar

  • 1ART Center, Department of Medicine, Institute of Medical Science, Banaras Hindu University, Varanasi 221 005, Uttar Pradesh, India. drdiptiagarwal@yahoo.co.in

Indian Pediatrics
|March 4, 2008
PubMed

Insights

In HIV-infected children, low CD4% (a measure of immune health) is linked to worsening clinical stages and severe malnutrition. This highlights the importance of monitoring CD4% for disease progression in pediatric HIV.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Public Health

Background:

  • Human Immunodeficiency Virus (HIV) infection remains a significant global health challenge, particularly in children.
  • Antiretroviral therapy (ART) is crucial for managing HIV, but early indicators of disease progression are vital for naive patients.
  • CD4% is a key marker of immune system health in HIV-infected individuals.

Purpose of the Study:

  • To investigate the correlation between CD4% and clinical status in antiretroviral naive children with HIV.
  • To assess the relationship between CD4% and the severity of WHO clinical stages and protein-energy malnutrition.

Main Methods:

  • A cross-sectional study was conducted involving 102 HIV-infected, antiretroviral naive children.
  • Data collected included age, mode of transmission, presenting symptoms, nutritional status (protein-energy malnutrition), WHO clinical stage, and CD4%.
  • Statistical analysis was performed to determine correlations.

Main Results:

  • The majority of children (94%) acquired HIV perinatally.
  • Common symptoms included fever, chronic diarrhea, and cough, with 56.7% experiencing protein-energy malnutrition.
  • A significant correlation was found between lower CD4% and advanced WHO clinical stages (P<0.01) and higher grades of protein-energy malnutrition (P<0.05).

Conclusions:

  • CD4% is a significant indicator of disease severity in HIV-infected children.
  • Monitoring CD4% is essential for assessing clinical status and nutritional challenges in pediatric HIV patients.
  • Early detection and intervention based on CD4% levels can help manage disease progression and improve outcomes.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...